HK1204920A1 - 含奈帕坦特的兒科口服液體組合物 - Google Patents

含奈帕坦特的兒科口服液體組合物

Info

Publication number
HK1204920A1
HK1204920A1 HK15105436.4A HK15105436A HK1204920A1 HK 1204920 A1 HK1204920 A1 HK 1204920A1 HK 15105436 A HK15105436 A HK 15105436A HK 1204920 A1 HK1204920 A1 HK 1204920A1
Authority
HK
Hong Kong
Prior art keywords
compositions containing
oral liquid
liquid compositions
pediatric oral
nepadutant
Prior art date
Application number
HK15105436.4A
Other languages
English (en)
Inventor
‧盧爾茲
‧施米茨
‧阿爾塔默
Original Assignee
Guidotti & C Spa Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guidotti & C Spa Labor filed Critical Guidotti & C Spa Labor
Publication of HK1204920A1 publication Critical patent/HK1204920A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK15105436.4A 2012-07-12 2015-06-08 含奈帕坦特的兒科口服液體組合物 HK1204920A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000331A ITRM20120331A1 (it) 2012-07-12 2012-07-12 Composizioni pediatriche orali liquide contenenti nepadutant.
PCT/IB2013/055754 WO2014009926A1 (en) 2012-07-12 2013-07-12 Pediatric oral liquid compositions containing nepadutant

Publications (1)

Publication Number Publication Date
HK1204920A1 true HK1204920A1 (zh) 2015-12-11

Family

ID=46939841

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105436.4A HK1204920A1 (zh) 2012-07-12 2015-06-08 含奈帕坦特的兒科口服液體組合物

Country Status (32)

Country Link
US (1) US9421268B2 (zh)
EP (1) EP2872137A1 (zh)
JP (1) JP6014252B2 (zh)
KR (1) KR20150030766A (zh)
CN (1) CN104507476B (zh)
AP (1) AP2015008224A0 (zh)
AU (1) AU2013288231B2 (zh)
BR (1) BR112015000647A2 (zh)
CA (1) CA2878817A1 (zh)
CL (1) CL2015000053A1 (zh)
CO (1) CO7240380A2 (zh)
CR (1) CR20150064A (zh)
EA (1) EA025618B1 (zh)
EC (1) ECSP15005163A (zh)
GE (1) GEP201606586B (zh)
GT (1) GT201500001A (zh)
HK (1) HK1204920A1 (zh)
IL (1) IL236667A0 (zh)
IN (1) IN2015DN00966A (zh)
IT (1) ITRM20120331A1 (zh)
MA (1) MA37845B2 (zh)
MX (1) MX2015000491A (zh)
NI (1) NI201500001A (zh)
NZ (1) NZ703090A (zh)
PE (1) PE20150865A1 (zh)
PH (1) PH12015500070B1 (zh)
SG (1) SG11201500095PA (zh)
TN (1) TN2014000515A1 (zh)
TW (1) TWI592167B (zh)
UA (1) UA112905C2 (zh)
WO (1) WO2014009926A1 (zh)
ZA (1) ZA201500978B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3634413A1 (en) 2017-06-09 2020-04-15 Exelixis, Inc. Liquid dosage forms to treat cancer
WO2024156799A1 (en) * 2023-01-27 2024-08-02 Hyloris Developments Sa Use of vitamin e tpgs as a taste masking agent for bitter drugs

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9203804A (es) 1987-10-19 1992-07-01 Liposome Co Inc Sistemas farmaceuticos a base de tocoferol.
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
HU215966B (hu) 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
IT1277835B1 (it) 1995-03-13 1997-11-12 Menarini Farma Ind Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
MY126358A (en) 1996-03-22 2006-09-29 Glaxo Group Ltd Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs
WO1998008490A1 (en) 1996-09-01 1998-03-05 Pharmos Corporation Solid coprecipitates for enhanced bioavailability of lipophilic substances
US5891845A (en) 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures
AR025587A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten
ITRM20030153A1 (it) 2003-04-03 2004-10-04 Exall S R L Formulazione idrosolubile contenente ubichinone per uso oftalmico.
JP4977611B2 (ja) 2004-09-24 2012-07-18 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 新規な種類の界面活性剤様物質
ITFI20040221A1 (it) * 2004-10-27 2005-01-27 Guidotti & C Spa Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition

Also Published As

Publication number Publication date
CL2015000053A1 (es) 2015-07-03
ZA201500978B (en) 2017-01-25
CO7240380A2 (es) 2015-04-17
ECSP15005163A (es) 2016-01-29
AP2015008224A0 (en) 2015-01-31
WO2014009926A1 (en) 2014-01-16
NZ703090A (en) 2016-06-24
BR112015000647A2 (pt) 2017-06-27
IN2015DN00966A (zh) 2015-06-12
GEP201606586B (en) 2016-12-12
UA112905C2 (uk) 2016-11-10
MA20150424A1 (fr) 2015-11-30
AU2013288231B2 (en) 2017-06-15
AU2013288231A1 (en) 2015-01-22
TN2014000515A1 (en) 2016-03-30
PE20150865A1 (es) 2015-06-10
ITRM20120331A1 (it) 2014-01-13
CN104507476B (zh) 2017-10-17
PH12015500070A1 (en) 2015-03-16
MA37845B2 (fr) 2017-10-31
GT201500001A (es) 2015-12-31
KR20150030766A (ko) 2015-03-20
PH12015500070B1 (en) 2015-03-16
US20150165034A1 (en) 2015-06-18
JP6014252B2 (ja) 2016-10-25
US9421268B2 (en) 2016-08-23
TW201408336A (zh) 2014-03-01
IL236667A0 (en) 2015-02-26
JP2015522063A (ja) 2015-08-03
EA025618B1 (ru) 2017-01-30
CN104507476A (zh) 2015-04-08
NI201500001A (es) 2015-09-18
SG11201500095PA (en) 2015-02-27
MX2015000491A (es) 2015-06-03
EA201500128A1 (ru) 2015-05-29
CR20150064A (es) 2015-04-30
CA2878817A1 (en) 2014-01-16
TWI592167B (zh) 2017-07-21
EP2872137A1 (en) 2015-05-20

Similar Documents

Publication Publication Date Title
IL290378A (en) Pharmaceutical compositions containing dimethyl fumarate
HK1208372A1 (zh) 液體製劑
HK1207819A1 (zh) 口腔用組合物
EP2725084A4 (en) LIQUID CRYSTAL COMPOSITION
HK1208177A1 (zh) 消旋卡多曲液體組合物
HK1255709A1 (zh) 液態化妝品
ZA201503890B (en) Oral care composition containing ionic liquids
HK1203772A1 (zh) 液態煙草組合物
EP2927301A4 (en) LIQUID CRYSTAL COMPOSITION
PT2935471T (pt) Composições líquidas curáveis
GB201201162D0 (en) Liquid cosmetic composition
EP2811005A4 (en) LIQUID CRYSTAL COMPOSITION
HK1211214A1 (zh) 液狀止汗用組合物
ZA201503850B (en) Oral care composition containing ionic liquids
EP2839825A4 (en) LIQUID COSMETIC PREPARATION
GB201205562D0 (en) Liquid insecticidal compositions
ZA201502036B (en) Liquid insecticidal composition
HK1214755A1 (zh) 牙科組合物
ZA201503888B (en) Oral care composition containing ionic liquids
HK1204920A1 (zh) 含奈帕坦特的兒科口服液體組合物
EP2895182A4 (en) DENTAL CLEANING COMPOSITION
EP2772141A4 (en) LIQUID SWEETENER COMPOSITION
EP2806012A4 (en) LIQUID CRYSTAL COMPOSITION
EP2830607A4 (en) POLYVINYLPYRROLIDONE-BASED ACETAMINOPHONE LIQUID FORMULATIONS
EP2859881A4 (en) ORAL COMPOSITION